Insulin receptor isoforms in physiology and disease: an updated view

A Belfiore, R Malaguarnera, V Vella… - Endocrine …, 2017 - academic.oup.com
The insulin receptor (IR) gene undergoes differential splicing that generates two IR isoforms,
IR-A and IR-B. The physiological roles of IR isoforms are incompletely understood and …

Insulin receptor isoforms in cancer

V Vella, A Milluzzo, NM Scalisi, P Vigneri… - International journal of …, 2018 - mdpi.com
The insulin receptor (IR) mediates both metabolic and mitogenic effects especially when
overexpressed or in clinical conditions with compensatory hyperinsulinemia, due to the …

[HTML][HTML] Insulin receptor isoforms and insulin growth factor-like receptors: implications in cell signaling, carcinogenesis, and chemoresistance

MA Galal, SS Alouch, BS Alsultan, H Dahman… - International Journal of …, 2023 - mdpi.com
This comprehensive review thoroughly explores the intricate involvement of insulin receptor
(IR) isoforms and insulin-like growth factor receptors (IGFRs) in the context of the insulin and …

PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis

V Vella, ML Nicolosi, S Giuliano, M Bellomo… - Frontiers in …, 2017 - frontiersin.org
It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are
associated to increased cancer incidence and mortality. Moreover, cancer development and …

Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity …

GP Shenoy, R Pal, GSP Matada, E Singh… - Bioorganic …, 2023 - Elsevier
Discoidin domain receptors (DDRs) are one of the less explored targets for the treatment of
cancer which belong to receptor tyrosine kinases family. Discoidin domain receptors (DDRs) …

Loss of E-cadherin Enhances IGF1–IGF1R pathway activation and sensitizes breast cancers to anti-IGF1R/InsR inhibitors

AM Nagle, KM Levine, N Tasdemir, JA Scott… - Clinical Cancer …, 2018 - aacrjournals.org
Purpose: Insulin-like growth factor 1 (IGF1) signaling regulates breast cancer initiation and
progression and associated cancer phenotypes. We previously identified E-cadherin …

[HTML][HTML] The insulin-like growth factor system and colorectal cancer

N Gligorijević, Z Dobrijević, M Šunderić, D Robajac… - Life, 2022 - mdpi.com
Insulin-like growth factors (IGFs) are peptides which exert mitogenic, endocrine and cytokine
activities. Together with their receptors, binding proteins and associated molecules, they …

Insulin resistance: any role in the changing epidemiology of thyroid cancer?

R Malaguarnera, V Vella, ML Nicolosi… - Frontiers in …, 2017 - frontiersin.org
In the past few decades, the incidence of thyroid cancer (TC), namely of its papillary
hystotype (PTC), has shown a steady increase worldwide, which has been attributed at least …

The effect of adipocyte–macrophage crosstalk in obesity-related breast cancer

AB Engin, A Engin, II Gonul - Journal of molecular …, 2019 - jme.bioscientifica.com
Adipose tissue is the primary source of many pro-inflammatory cytokines in obesity.
Macrophage numbers and pro-inflammatory gene expression are positively associated with …

IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway

R Matà, C Palladino, ML Nicolosi, ARL Presti… - …, 2015 - pmc.ncbi.nlm.nih.gov
Discoidin Domain Receptor 1 (DDR1) is a collagen receptor tyrosine-kinase that contributes
to epithelial-to-mesenchymal transition and enhances cancer progression. Our previous …